President of Europe Sells $475K in Company Stock Following Strong Earnings Report
NATR has more than doubled off its 52-week low of $11.01.
Summary
A key executive, Bryant J. Yates, sold $475,215 worth of company stock in an open market transaction, reducing his direct holdings.
Key Events · Ownership and Investor Activity · NATR
-
Key Executive Sells Shares
Bryant J. Yates, EVP & President of Europe, disposed of 19,516 common shares in an open market sale.
-
Significant Transaction Value
The sale was valued at $475,214.60, with shares sold at a price of $24.35 each on March 13, 2026.
-
Reduced Holdings
Following the transaction, Mr. Yates' direct holdings in the company decreased to 85,154 shares.
-
Follows Strong Earnings
This sale occurs shortly after the company reported strong Q4 and full-year 2025 results on March 10, 2026.
Analysis · NATR · Life Sciences
Bryant J. Yates, the EVP & President of Europe for Nature's Sunshine Products, executed an open market sale of shares valued at $475,215. This transaction, occurring shortly after the company reported strong fourth-quarter and full-year 2025 financial results, represents a notable distribution of shares by a key executive. While the company recently announced positive performance, a significant insider sale can be interpreted as a signal of reduced conviction or a move to lock in gains, potentially offsetting some of the positive sentiment from the earnings report. This sale contributes to a broader pattern of net insider distribution over the last 90 days.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NATR was trading at $23.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $420M. The 52-week trading range was $11.01 to $28.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.